Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Rabeah Al-Temaimi"'
Autor:
Rabeah Al-Temaimi, Raed Alroughani
Publikováno v:
Heliyon, Vol 10, Iss 12, Pp e32685- (2024)
Multiple sclerosis (MS) is a complex, neurodegenerative chronic disorder. Circulating diagnostic biomarkers for MS have remained elusive, and those proposed so far have limited sensitivity and specificity to MS. Plasma-circulating microRNAs (miRNAs)
Externí odkaz:
https://doaj.org/article/48b44601a9134a70bf246d11c8528da3
Publikováno v:
BMC Microbiology, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Thymol is a phenolic compound used for its wide spectrum antimicrobial activity. There is a limited understanding of the antimicrobial mechanisms underlying thymol activity. To investigate this, E. coli strain JM109 was exposed to
Externí odkaz:
https://doaj.org/article/cb7d09602c744f4fbe7e0a75137fda24
Autor:
Rabeah Al-Temaimi, Kusum Kapila, Fahd R Al-Mulla, Issam M Francis, Salah Al-Waheeb, Bushra Al-Ayadhy
Publikováno v:
Journal of Cytology, Vol 33, Iss 1, Pp 1-6 (2016)
Context: Nonsmall cell lung carcinoma (NSCLC) is the most frequently diagnosed form of lung cancer in Kuwait. NSCLC samples from Kuwait have never been screened for epidermal growth factor receptor (EGFR) gene aberration, which is known to affect tre
Externí odkaz:
https://doaj.org/article/330dcd089ced4468821a1356083df890
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-6 (2019)
Scientific Reports
Scientific Reports
Obesity is a well-known risk factor for multiple diseases including multiple sclerosis (MS). Polymorphisms in the fat-mass obesity (FTO) gene have been consistently found to be associated with obesity, and recently found to increase the risk of devel
GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Publikováno v:
Multiple Sclerosis and Demyelinating Disorders, Vol 4, Iss 1, Pp 1-6 (2019)
Background Currently, there are few established pharmacogenetic predictors of response to treatment in multiple sclerosis (MS) patients. Commonly used second line treatments include natalizumab that has proven to be successful in slowing MS progressi
Autor:
Bushra Al-Ayadhy, Fatma Jasem Mothafar, Issam M. Francis, Kusum Kapila, Mohammed Jaragh, Rabeah Al-Temaimi, Preeta Alath
Publikováno v:
Journal of Cytology
Journal of Cytology, Vol 36, Iss 2, Pp 94-100 (2019)
Journal of Cytology, Vol 36, Iss 2, Pp 94-100 (2019)
Introduction: Estrogen receptors (ER), progesterone receptors (PR), and epidermal growth factor (HER2) are prognostic and predictive factors for breast carcinoma. We determined them by immunohistochemistry (IHC) on cell blocks from fine-needle aspira
Publikováno v:
Int J MS Care
Background: Multiple sclerosis (MS) is a demyelinating autoimmune disorder. Several factors have been shown to associate with MS clinical severity. The influence of different lifestyle factors on MS clinical severity as assessed by the Multiple Scler
Autor:
Ahmad Al-Serri, Suzanne A. Al-Bustan, Nabila Abdella, Daisy Thomas, Osama Alsmadi, Rabeah Al-Temaimi, Olusegun A. Mojiminiyi, Maisa Mahmoud Kamkar
Publikováno v:
Medical Principles and Practice. 27:145-151
Objective: To investigate the effect of the common fat mass and obesity-associated (FTO) gene polymorphism rs9939609 on body mass index (BMI) in one of the most obese populations worldwide. Subjects and Methods: Genotypic data for FTO rs9939609 were
Publikováno v:
Experimental and Molecular Pathology. 103:237-241
Multiple Sclerosis (MS) is a complex autoimmune neuro-inflammatory disorder characterized by persistent MS plaques in the central nervous system. Resolution of MS plaques is dependent on the remyelination competence of surviving oligodendrocytes and
Publikováno v:
NeuroMolecular Medicine. 19:286-292
Multiple sclerosis (MS) exhibits sex bias in disease clinical course as male MS patients develop severe, progressive clinical course with accumulating disability. So far, no factors have been found associating with this sex bias in MS severity. We se